Showing results (1-10 of 175) with videos related to
Sort By:
Pageof 18
Trends in Molecular Medicine|March 14, 2017
A Brighter Side to Thalidomide: Its Potential Use in Immunological DisordersDavid Millrine, Tadamitsu KishimotoProceedings of the National Academy of Sciences of the United States of America|September 8, 2016
Rabex-5 is a lenalidomide target molecule that negatively regulates TLR-induced type 1 IFN productionDavid Millrine, Mami Tei, Yohannes Gemechu, et al.Proceedings of the National Academy of Sciences of the United States of America|October 31, 2018
Humanized cereblon mice revealed two distinct therapeutic pathways of immunomodulatory drugsYohannes Gemechu, David Millrine, Shigeru Hashimoto, et al.International Immunology|February 12, 2016
Immunomodulatory drugs inhibit TLR4-induced type-1 interferon production independently of Cereblon via suppression of the TRIF/IRF3 pathwayDavid Millrine, Haruhiko Miyata, Mami Tei, et al.The Keio Journal of Medicine|December 26, 2019
Discovery of IL-6 and Development of Anti-IL-6R AntibodyTadamitsu KishimotoArthritis Research & Therapy|August 11, 2006
Interleukin-6: discovery of a pleiotropic cytokineTadamitsu KishimotoInternational Archives of Allergy and Immunology|June 25, 2021
lnterleukin-6 and Its Receptor; From Cloning to ClinicTadamitsu KishimotoAnnual Review of Immunology|March 18, 2005
Interleukin-6: from basic science to medicine--40 years in immunologyTadamitsu KishimotoClinical Reviews in Allergy & Immunology|September 1, 2005
IL-6: from laboratory to bedsideTadamitsu KishimotoInternational Immunology|April 23, 2010
IL-6: from its discovery to clinical applicationsTadamitsu KishimotoPageof 18